TABLE 2.
Characteristic | Survival, Median (Range), mo | Crude HR (95% CI)* | aHR (95% CI)*† |
---|---|---|---|
Age at menarche, y | |||
<12 | 56 (1–30) | Reference | Reference |
12 | 52 (8–371) | 0.98 (0.70–1.37) | 1.04 (0.74–1.47) |
13 | 50 (2–359) | 0.86 (0.62–1.21) | 1.01 (0.72–1.43) |
≥14 | 67 (3–386) | 0.77 (0.55–1.09) | 0.95 (0.67–1.35) |
Menstrual regularity | |||
Regular | 56 (1–386) | Reference | Reference |
Irregular | 72 (3–346) | 0.77 (0.54–1.10) | 0.99 (0.69–1.42) |
Ever used OCs | |||
No | 46 (1–386) | Reference | Reference |
Yes | 81 (3–375) | 0.51 (0.39–0.66) | 0.71 (0.53–0.97) |
Ever pregnant | |||
No | 60 (7–386) | Reference | Reference |
Yes | 56 (1–375) | 1.15 (0.87–1.51) | 0.76 (0.57–1.01) |
Ever live birth | |||
No | 60 (7–386) | Reference | Reference |
Yes | 56 (1–375) | 1.13 (0.86–1.47) | 0.80 (0.60–1.06) |
No. births | |||
None | 60 (7–386) | Reference | Reference |
1 | 89 (11–375) | 0.83 (0.56–1.24) | 0.72 (0.48–1.08) |
2 | 60 (3–341) | 1.05 (0.75–1.47) | 0.78 (0.55–1.11) |
3 | 44 (2–335) | 1.30 (0.93–1.83) | 0.88 (0.62–1.26) |
4+ | 41 (1–371) | 1.29 (0.93–1.80) | 0.81 (0.57–1.14) |
Ever had tubal ligation | |||
No | 68 (1–375) | Reference | Reference |
Yes | 56 (3–386) | 0.64 (0.43–0.93) | 0.90 (0.60–1.34) |
Lifetime duration of breastfeeding | |||
None | 61 (1–386) | Reference | Reference |
<1 y | 50 (2–339) | 1.31 (1.00–1.70) | 1.00 (0.76–1.32) |
1–2 y | 76 (8–341) | 0.75 (0.47–1.19) | 0.68 (0.43–1.08) |
≥2 y | 29 (8–297) | 1.48 (0.89–2.47) | 0.92 (0.54–1.58) |
HRs and 95% CIs computed using Cox proportional hazards models.
Adjusted for FIGO stage, age at diagnosis, and histology.